Shukra Pharmaceuticals Ltd SHARE PRICE [LIVE]

  
NSE: SHUKRAPHAR
N/A
BSE: 524632
262.60
To view real time prices Login to your account
OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality

Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Not Applicable
Sector
-9.45%
Sensex
1.72%
IndustryPharma
MARKET CAP (Micro Cap Stock)Rs Cr
PE (TTM) 0.00
DIVIDEND YIELD 0.00%
PE Ratio35.28
Price to Book Value2.34
EV to EBIT25.18
EV to EBITDA11.77
EV to Capital Employed2.29
EV to Sales1.80
PEG Ratio0.00
Dividend Yield0.20%
ROCE (Latest)9.09%
ROE (Latest)6.62%
NameDec 22Sep 22
Promoters (Change:0.00) 49.17%49.17%
FIIs (Change:0.00) 0%0%
Mutual Funds (Change:0.00) 0%0%
Insurance Companies (Change:0.00) 0%0%
Other DIIs (Change:0.00) 0.8%0.8%
Non Institution (Change:0.00) 50.04%50.04%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Shukra Pharmaceuticals Ltd

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

SHUKRAPHAR News

Frequently Asked Questions

What is the Share price of Shukra Pharmaceuticals Ltd (SHUKRAPHAR)?

Shukra Pharmaceuticals Ltd (SHUKRAPHAR) share price as of February 1, 2023, on BSE is Rs 262.60 (BSE).

Can I buy Shukra Pharmaceuticals Ltd (SHUKRAPHAR) shares?

Yes, You can buy Shukra Pharmaceuticals Ltd (SHUKRAPHAR) shares by opening a Demat account with Angel One.

How do I buy Shukra Pharmaceuticals Ltd (SHUKRAPHAR) from Angel One?

Shukra Pharmaceuticals Ltd (SHUKRAPHAR) share can be brought through the following modes:
  1. Direct investment: You can buy Shukra Pharmaceuticals Ltd (SHUKRAPHAR) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Shukra Pharmaceuticals Ltd (SHUKRAPHAR) shares.

In which sector do Shukra Pharmaceuticals Ltd (SHUKRAPHAR) belong?

Shukra Pharmaceuticals Ltd (SHUKRAPHAR) belongs to Pharma.

About SHUKRAPHAR

Today's live share price for Shukra Pharmaceuticals Ltd is NSE: N/A, BSE: ₹ 262.60 with a current market capitalization of .

Relish Pharmaceuticals Ltd is a public limited company with a global perspective, manufacturing, exporting and marketing in both domestic and international markets. The company was incorporated on March 4, 1993 as a private limited company with the name Relish Pharmaceuticals Pvt Ltd. In August 31, 1993, the company was converted into a public limited company and the name was changed to Relish Pharmaceuticals Ltd. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others. The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat. The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc. The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers